Current findings of kidney biopsy including nephropathy associated with hypertension and diabetes mellitus in Korea
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background/Aims: This study aimed to investigate long-term temporal trends and outcomes of biopsy-proven kidney diseases in a multicenter kidney biopsy cohort, focusing on hypertension and diabetes, the leading causes of end-stage kidney disease (ESKD). Methods: The study included a total of 21,426 patients who underwent kidney biopsy from 1979 to 2018 in 18 hospitals in Korea. We selected subgroups of adults with diabetes (n = 2,813) or clinically presumed hypertensive nephrosclerosis (HTN, n = 2,917). Clinical, demographic, and laboratory data were collected in conjunction with pathologic findings. The prevalence of pathologically confirmed kidney diseases over time and their associations with clinical outcomes were evaluated. Results: The prevalence of biopsy-proven diabetic nephropathy (DN) has increased significantly from 2.5% to 6.0% in the total cohort in the recent 30 years with an increase in the prevalence of diabetes. Approximately 68% of total diabetic patients had non-diabetic renal disease (NDRD); the proportion was retained since 2000s. DN showed a significantly higher risk of ESKD than NDRD (hazard ratio [HR], 1.59; 95% confidence interval [CI], 1.35 to 1.88). The prevalence of biopsy- proven HT-N remained < 2% in the total cohort for several decades. There was no difference in risks of ESKD between patients with or without biopsy-proven HT-N (HR, 0.93; 95% CI, 0.54 to 1.59). Conclusions: In recent decades, the prevalence of diabetes and DN has significantly increased in the kidney biopsy cohort, showing an increased risk of ESKD. Despite the large numbers of patients meeting the clinical criteria of HT-N, most of those were diagnosed with pathologic diagnoses other than HT-N.
Abstract
Background/Aims: This study aimed to investigate long-term temporal trends and outcomes of biopsy-proven kidney diseases in a multicenter kidney biopsy cohort, focusing on hypertension and diabetes, the leading causes of end-stage kidney disease (ESKD). Methods: The study included a total of 21,426 patients who underwent kidney biopsy from 1979 to 2018 in 18 hospitals in Korea. We selected subgroups of adults with diabetes (n = 2,813) or clinically presumed hypertensive nephrosclerosis (HTN, n = 2,917). Clinical, demographic, and laboratory data were collected in conjunction with pathologic findings. The prevalence of pathologically confirmed kidney diseases over time and their associations with clinical outcomes were evaluated. Results: The prevalence of biopsy-proven diabetic nephropathy (DN) has increased significantly from 2.5% to 6.0% in the total cohort in the recent 30 years with an increase in the prevalence of diabetes. Approximately 68% of total diabetic patients had non-diabetic renal disease (NDRD); the proportion was retained since 2000s. DN showed a significantly higher risk of ESKD than NDRD (hazard ratio [HR], 1.59; 95% confidence interval [CI], 1.35 to 1.88). The prevalence of biopsy- proven HT-N remained < 2% in the total cohort for several decades. There was no difference in risks of ESKD between patients with or without biopsy-proven HT-N (HR, 0.93; 95% CI, 0.54 to 1.59). Conclusions: In recent decades, the prevalence of diabetes and DN has significantly increased in the kidney biopsy cohort, showing an increased risk of ESKD. Despite the large numbers of patients meeting the clinical criteria of HT-N, most of those were diagnosed with pathologic diagnoses other than HT-N.
참고문헌 (51)
- Connor KL, "MicroRNAs as non-invasive biomarkers of renal disease", Nephrol Dial Transplant (2019)[DOI]
- Taherkhani A, "Chronic kidney disease : a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers", Proteome Sci, 17, pp.7~ (2019)
- Dhaun N, "Utility of renal biopsy in the clinical management of renal disease", Kidney Int, 85, pp.1039~1048 (2014)
- Brkovic V, "Does the pathohistological pattern of renal biopsy change during time", Pathol Res Pract, 214, pp.1632~1637 (2018)
- Fiorentino M, "Renal biopsy in 2015 : from epidemiology to evidence-based indications", Am J Nephrol, 43, pp.1~19 (2016)
- Chiu HF, "Distribution of glomerular diseases in Taiwan : preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology", BMC Nephrol, 19, pp.6~ (2018)
- Al Turk AA, "Trends and outcomes of the use of percutaneous native kidney biopsy in the United States : 5-year data analysis of the Nationwide Inpatient Sample", Clin Kidney J, 11, pp.330~336 (2018)
- 임태훈, "Patterns in renal diseases diagnosed by kidney biopsy: A single-center experience", Kidney Research and Clinical Practice, 39(1), pp.60~69 (2020), 대한신장학회[DOI]
- NCD Risk Factor Collaboration(NCD-RisC), "Worldwide trends in diabetes since 1980: a pooled analysis of 751population-based studies with 4.4 million participants", Lancet, 387, pp.1513~1530 (2016)
- Kearney PM, "Global burden of hypertension : analysis of worldwide data", Lancet, 365, pp.217~223 (2005)
- Ghaderian SB, "The role of diabetes mellitus and hypertension in chronic kidney disease", J Renal Inj Prev, 3, pp.109~110 (2014)
- Tervaert TW, "Pathologic classification of diabetic nephropathy", J Am Soc Nephrol, 21, pp.556~563 (2010)
- Freedman BI, "Renal biopsy findings in presumed hypertensive nephrosclerosis", Am J Nephrol, 14, pp.90~94 (1994)
- Harvey JM, "Renal biopsy findings in hypertensive patients with proteinuria", Lancet, 340, pp.1435~1436 (1992)
- Fiorentino M, "Renal biopsy in patients with diabetes : a pooled meta-analysis of 48 studies", Nephrol Dial Transplant, 32, pp.97~110 (2017)
- Zarif L, "Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis", Nephrol Dial Transplant, 15, pp.1801~1807 (2000)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group", Ann Intern Med, 130, pp.461~470 (1999)
- Fogo A, "Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans:a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators", Kidney Int, 51, pp.244~252 (1997)
- Shin HS, "Patterns of renal disease in South Korea : a 20-year review of a single-center renal biopsy database", Ren Fail, 39, pp.540~546 (2017)
- Su S, "Clinicopathologic correlations of renal biopsy findings from northeast China:a 10-year retrospective study", Medicine (Baltimore), 98, pp.e15880~ (2019)
- Zhou Q, "Changes in the diagnosis of glomerular diseases in east China : a 15-year renal biopsy study", Ren Fail, 40, pp.657~664 (2018)
- Rivera F, "Clinicopathologic correlations of renal pathology in Spain", Kidney Int, 66, pp.898~904 (2004)
- van Paassen P, "Signs and symptoms of thin basement membrane nephropathy : a prospective regional study on primary glomerular disease : The Limburg Renal Registry", Kidney Int, 66, pp.909~913 (2004)
- 노정현, "The Diabetes Epidemic in Korea", Endocrinology and Metabolism, 31(3), pp.349~353 (2016), 대한내분비학회
- Global Burden of Disease Study 2013 Collaborators, "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 386, pp.743~800 (2015)
- 변자민, "Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes", The Korean Journal of Internal Medicine, 28(5), pp.565~572 (2013), 대한내과학회[DOI]
- Soleymanian T, "Non-diabetic renal disease with or without diabetic nephropathy in type 2 diabetes : clinical predictors and outcome", Ren Fail, 37, pp.572~575 (2015)
- 진동찬, "Lessons from 30 years’ data of Korean end-stage renal disease registry, 1985–2015", Kidney Research and Clinical Practice, 34(3), pp.132~139 (2015), 대한신장학회
- National Institutes of Health, "2007 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States" (2007), Saunders
- Atkins RC, "The epidemiology of chronic kidney disease", Kidney Int Suppl, 94, pp.S14~S18 (2005)
- Bermejo S, "The current role of renal biopsy in diabetic patients", Minerva Med, 109, pp.116~125 (2018)
- Christensen PK, "Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy", Kidney Int, 58, pp.1719~1731 (2000)
- Parving HH, "Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients", Kidney Int, 41, pp.758~762 (1992)
- Li L, "Renal pathological implications in type 2 diabetes mellitus patients with renal involvement", J Diabetes Complications, 31, pp.114~121 (2017)
- KDOQI, "KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease", Am J Kidney Dis, 49(2 Suppl 2), pp.S12~S154 (2007)
- Liang S, "Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus : a meta-analysis", PLoS One, 8, pp.e64184~ (2013)
- Zhou J, "A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases", Nephrol Dial Transplant, 23, pp.1940~1945 (2008)
- Liu MY, "Validation of a differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases and the establishment of a new diagnostic model", J Diabetes, 6, pp.519~526 (2014)
- 김태종, "Trends in Blood Pressure and Prevalence of Hypertension in Korean Adults Based on the 1998–2014 KNHANES", Yonsei Medical Journal, 59(3), pp.356~365 (2018), 연세대학교의과대학[DOI]
- Takebayashi S, "Benign nephrosclerosis : incidence, morphology and prognosis", Clin Nephrol, 55, pp.349~356 (2001)
- Innes A, "Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy", Q J Med, 86, pp.271~275 (1993)
- Vikse BE, "Clinical prognostic factors in biopsy-proven benign nephrosclerosis", Nephrol Dial Transplant, 18, pp.517~523 (2003)
- Freedman BI, "Hypertension-attributed nephropathy : what’s in a name", Nat Rev Nephrol, 12, pp.27~36 (2016)
- Wang XC, "Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy", Exp Ther Med, 6, pp.1243~1246 (2013)
- Meyrier A, "Nephrosclerosis : a term in quest of a disease", Nephron, 129, pp.276~282 (2015)
- Ovrehus MA, "Clinical phenotypes and long-term prognosis in white patients with biopsy-verified hypertensive nephrosclerosis", Kidney Int Rep, 5, pp.339~347 (2019)
- Sugiyama H, "Japan Renal Biopsy Registry and Japan Kidney Disease Registry : committee report for 2009 and 2010", Clin Exp Nephrol, 17, pp.155~173 (2013)
- Li LS, "Epidemiologic data of renal diseases from a single unit in China : analysis based on 13, 519 renal biopsies", Kidney Int, 66, pp.920~923 (2004)
- McGrogan A, "The incidence of primary glomerulonephritis worldwide : a systematic review of the literature", Nephrol Dial Transplant, 26, pp.414~430 (2011)
- Moroni G, "Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis", Ann Rheum Dis, 77, pp.1318~1325 (2018)
- Kopp JB, "Rethinking hypertensive kidney disease : arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder", Curr Opin Nephrol Hypertens, 22, pp.266~272 (2013)
